Announcements Trials

Browse Landscape

Phase

Status

Unknown 3 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 27 Breast 15 Thoracic 7 Head & Neck 6 Gynecologic 6 Sarcoma 4 Genitourinary 4 Lymphoid 3 Tumor-Agnostic 2 Plasma cell 1 Endocrine 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 98 daratumumab 57 Lenalidomide 53 Bortezomib 38 pomalidomide 37 Cyclophosphamide 37 carfilzomib 25 Calcium Dobesilate 25 fludarabine 22 talquetamab 19 iberdomide 18 isatuximab 17 Specimen Handling 17 Magnetic Resonance Spectroscopy 17 Biopsy 15 selinexor 13 dexamethasone acetate 12 belantamab mafodotin 12 Melphalan 12 dexamethasone 21-phosphate 11 auricularum 10 venetoclax 8 fludarabine phosphate 7 elotuzumab 7 X-Rays 6 tocilizumab 5 Blood Specimen Collection 5 ruxolitinib 4 ixazomib 4 Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoadjuvant Therapy × Plasma cell × Clear all

NCT07149857 2026-05-08

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡